Cleared Traditional

K840391 - ANGIOGRAPHIC PROCEDURE TRAY

K840391 is an FDA 510(k) clearance for ANGIOGRAPHIC PROCEDURE TRAY, manufactured by Triad Medical Division. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 210-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1984
Decision
210d
Days
Class 2
Risk

K840391 is an FDA 510(k) clearance for the ANGIOGRAPHIC PROCEDURE TRAY. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Triad Medical Division (Norcross, US). The FDA issued a Cleared decision on August 27, 1984 after a review of 210 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Triad Medical Division devices

FDA 510(k) Submission Details - K840391

510(k) Number K840391 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 30, 1984
Decision Date August 27, 1984
Days to Decision 210 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
85d slower than avg
Panel avg: 125d · This submission: 210d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 714
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K840391.
BIOPATCH BOVINE PERICARDIAL PATCH
K840756 · Meadox Medicals, Div. Boston Scientific Corp. · Feb 1985
HYDROGLIDE SPRING GUIDE WIRES
K841926 · Argon Medical Corp. · Jan 1985
WIREGUIDE OR GUIDEWIRE
K843012 · Medi-Tech, Inc. · Nov 1984
CARDIOVASCULAR SPRING GUIDE WIRE
K834223 · Mallinckrodt Critical Care · Feb 1984
OPEN END SPRING GUIDE
K832607 · C.R. Bard, Inc. · Dec 1983
STAINLESS STEEL GUIDE WIRE
K831839 · Quinton, Inc. · Jul 1983